LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized; enrollment completion expected in 3Q 2025 – – Topline 56-week data for LUGANO expected in mid-2026 with ...

Lupin has signed a licence and supply agreement with SteinCares to commercialise its biosimilar ranibizumab in Latin American ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being ...

The global sales of ophthalmic lasers are estimated to be worth USD 976.8 million in 2024 and are anticipated to reach a value of USD 1,561.0 million by 2034. Sales are projected to rise at a CAGR of ...

Low and high high-density lipoprotein (HDL) are associated with an increased risk for age-related macular degeneration (AMD), ...

Oral 8-aminoguanine (8-AG) treatment preserved retinal structure and rod function in aged Fischer 344 rats, significantly ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.